Citation Impact
Citing Papers
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
The Oncogenic Potential of Hepatitis C Virus NS5A Sequence Variants Is Associated with PKR Regulation
2005
Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect
2008
To Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon
2002
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Hepatocellular carcinoma
2003 Standout
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
Molecular pathogenesis of human hepatocellular carcinoma
2002
HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV
2004
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR
2002 Standout
Hepatitis C Virus Infection
2001 Standout
How Hepatitis C Virus Counteracts the Interferon Response: The Jury Is Still out on NS5A
2001
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Diagnostic tests for hepatitis C
1999
Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels
1998
Developments in Quantitative PCR
1998
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
Quantification of Serum Hepatitis C Virus RNA with Daily or Standard Interferon Doses Plus Ribavirin in Nonresponder Patients with Chronic Hepatitis C
2000
Viral Dynamics of Hepatitis C Early After Orthotopic Liver Transplantation: Evidence for Rapid Turnover of Serum Virions
1996
A new mathematical model for relative quantification in real-time RT-PCR
2001 Standout
Mesenchymal stem cells in health and disease
2008 Standout
Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase
2009
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Establishment of persistent hepatitis C virus infection and replication in vitro.
1997
Combination of interferon induction therapy and ribavirin in chronic hepatitis C
2001
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
1999
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Silencing of USP18 Potentiates the Antiviral Activity of Interferon Against Hepatitis C Virus Infection
2006 StandoutNobel
Mesenchymal stem cells in tumor development
2012
Measurement of biological information with applications from genes to landscapes
2006
Detection of widespread hepatocyte infection in chronic hepatitis C
1998
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Antibody neutralization and escape by HIV-1
2003 StandoutNature
Molecular Characterization of Hepatitis C Virus
1998 StandoutNobel
Hepatitis C virus–specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
2000
Viral Dynamics and Response Differences in Hcv–Infected African American and White Patients Treated With Ifn and Ribavirin
2003
Recent advances into the understanding of mesenchymal stem cell trafficking
2007
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Mutations in the Nonstructural 5A Gene of European Hepatitis C Virus Isolates and Response to Interferon Alfa
1997
Interleukin‐6 maintains bone marrow‐derived mesenchymal stem cell stemness by an ERK1/2‐dependent mechanism
2009
Hepatitis C virus genotypes and quasispecies
1999
VIRUSES AND THE TYPE I INTERFERON ANTIVIRAL SYSTEM: INDUCTION AND EVASION
2002
Cancer immunotherapy comes of age
2011 StandoutNature
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame
2001
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
2000
Hypersusceptibility to Vesicular Stomatitis Virus Infection in Dicer1-Deficient Mice Is Due to Impaired miR24 and miR93 Expression
2007 StandoutNobel
A new step toward standardization of serum hepatitis C Virus-RNA quantification in patients with chronic hepatitis C
2000
The role of senescent cells in ageing
2014 StandoutNature
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo
2017 StandoutNobel
The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein
2004 StandoutNobel
Pathogenesis, diagnosis and management of hepatitis C
2000
Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver
2003
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications
2017 StandoutNobel
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
1999
Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation
1999 StandoutNobel
Activation and evasion of the antiviral 2???-5??? oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA
2002
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C
2001
Hepatitis C virus sequences from different patients confirm the existence and transmissibility of subtype 2q, a rare subtype circulating in the metropolitan area of Barcelona, Spain
2011
Replication of hepatitis C virus
2007 StandoutNobel
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic Protein 1 in lymphopoiesis and innate immunity
2008 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
TaqMan 5′-Nuclease Human Immunodeficiency Virus Type 1 PCR Assay with Phage-Packaged Competitive Internal Control for High-Throughput Blood Donor Screening
2001
Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro
2002
GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research—an update
2012 Standout
Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy
1999
Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis
2005
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection
2002
Course and outcome of hepatitis C
2002
Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue
2016
Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C
2001
Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing
2007 Standout
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation
1998
Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations
1998
Quasispecies Heterogeneity within the E1/E2 Region as a Pretreatment Variable during Pegylated Interferon Therapy of Chronic Hepatitis C Virus Infection
2005
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
2005 StandoutScience
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
Hepatitis C Virus NS5A Physically Associates with p53 and Regulates p21/waf1 Gene Expression in a p53-Dependent Manner
2001
Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action
2006
Poly(butylene terephthalate) electrospun/melt‐blown composite mats for white blood cell filtration
2012
Comparative Study of Different Standardization Concepts in Quantitative Competitive Reverse Transcription-PCR Assays
1998
Viral Quasispecies Evolution
2012
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 StandoutScience
Second-generation line probe assay for hepatitis C virus genotyping
1996
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton
2006
Effects of Mutation in Hepatitis C Virus Nonstructural Protein 5A on Interferon Resistance Mediated by Inhibition of PKR Kinase Activity in Mammalian Cells
2001
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Brigitte Rüster being referenced
Evaluation of a reverse hybridization assay for genotyping of hepatitis C virus
1995
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo
1996
Interferon Alfa Down–Regulates Cd81 in Patients With Chronic Hepatitis C
2001
Mutations in the Protein Kinase–Binding Domain of the NS5A Protein in Patients Infected with Hepatitis C Virus Type 1a Are Associated with Treatment Response
2000
Analysis of leukocyte binding to depletion filters: role of passive binding, interaction with platelets, and plasma components
2005
Hepatitis C Virus Sequences Encoding Truncated Core Proteins Detected in a Hepatocellular Carcinoma
1996
Quantification of Hepatitis C Virus RNA by Competitive Reverse Transcription and Polymerase Chain Reaction Using a Modified Hepatitis C Virus RNA Transcript
1995
Phylogenetic Analysis of Hepatitis C Virus Isolates and Their Correlation to Viremia, Liver Function Tests, and Histolog
1996
Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response
2000
Quasispecies Heterogeneity of the Carboxy-Terminal Part of the E2 Gene Including the PePHD and Sensitivity of Hepatitis C Virus 1b Isolates to Antiviral Therapy
2001
Comparison of TaqMan™ real-time PCR and p24 Elisa for quantification of in vitro HIV-1 replication
2002
Quantification of the initial decline of serum hepatitis c virus RNA and response to interferon alfa
1998
The AF4·MLL fusion protein is capable of inducing ALL in mice without requirement of MLL·AF4
2010
Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of hepatitis C virus.
1994
Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels
2000
Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays
1996
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells
2006